Suffering from Ozempic, Rybelsus or Wegovy
Side Effects?
Take Action Now

If you have taken the semaglutides Ozempic, Wegovy, or Rybelsus and are suffering from Severe Gastrointestinal Symptoms or have been diagnosed with Gastroparesis (Stomach Paralysis) or Gallbladder Disease, you may be eligible for compensation.

Get Your Free Case Review Today

First Name
Last Name
Phone Number
Email Address
Additional Info
Satisfied Clients
Weight Loss Medications Linked to Severe Gastrointestinal Issues

Weight Loss Medications Linked to Severe Gastrointestinal Issues

Ozempic has been hailed as a breakthrough for weight loss and diabetes management, but behind its success lies a disturbing reality. Patients are now coming forward with claims of severe gastrointestinal complications, including gastroparesis, stomach paralysis, and life-threatening intestinal blockages. Lawsuits accuse drug manufacturers of failing to warn consumers about these risks, leaving many to suffer in silence. As reports of excruciating pain, uncontrollable vomiting, and emergency surgeries mount, the truth about Ozempic’s hidden dangers is finally coming to light.

Weight Loss Medications Linked to Severe Gastrointestinal Issues
Ongoing Case Evaluations: Compensation May Be Available

Ongoing Case Evaluations: Compensation May Be Available

Patients who took Ozempic and other GLP-1 medications are now facing devastating health complications, including gastroparesis, intestinal blockages, and severe digestive issues. Many claim they were never warned about these risks, leading to life-altering conditions, emergency surgeries, and relentless suffering. As mass tort lawsuits move forward, victims may be entitled to significant compensation for medical expenses, lost wages, and pain and suffering. If you’ve experienced these complications, now is the time to explore your legal options.

Proven Results You Can Trust

At Bursor & Fisher, P.A., we are dedicated to securing the highest verdicts and settlements for our clients, ensuring they receive the full compensation they rightfully deserve.
Jury Verdict of $267M Against debt collector that made millions on illegal robocalls.

Trial Victory of $299M For class of 1.9 million Sprint customers who were charged illegal fees.

We represented 3,000+ Military veterans and family of military veterans injured or killed by exposure to toxic water at Camp Lejeune.

We're Here To Help You Win

Scott A. Bursor President
Scott A. Bursor is the President of Bursor & Fisher, P.A. He focuses his practice on complex civil litigation and class actions. Class actions rarely go to trial. Scott tried 6 class action cases to juries, and won all 6, achieving awards ranging from $21 million to $299 million. Scott’s most recent trial victory came in May 2019 in Perez v. Rash Curtis & Associates, in federal court in Oakland, California, where he won a $267 million jury verdict against a debt collector for violations of the Telephone Consumer Protection Act (TCPA).
Sarah N. Westcot Managing Partner
Sarah N. Westcot is the Managing Partner of Bursor & Fisher’s Miami office. Sarah is an experienced litigator who has devoted her practice to seeking justice for clients who have been injured and wronged. Sarah has been chosen by judges to serve on Plaintiff Steering Committees and Plaintiff Executive Committees in national litigations included In re Oral Phenylephrine Marketing and Sales Practices Litigation (MDL No. 3089), In re Zantac (Ranitidine) Products Liability Litigation (MDL No. 2924), In re Apple Inc. App Store Simulated Casino-Style Games Litigation (MDL No 2985), and In Re: Google Play Store Simulated Casino-Style Games Litigation (MDL No. 3001).